Almirall, S.A. (ALM.MC)
EUR 8.31
(1.03%)
EUR 8.31
(1.03%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 894.51 Million EUR | 4.12% |
| 2022 | 863.24 Million EUR | 4.36% |
| 2021 | 827.19 Million EUR | -48.78% |
| 2020 | 1.61 Billion EUR | 88.8% |
| 2019 | 855.33 Million EUR | 13.0% |
| 2018 | 756.93 Million EUR | 18.39% |
| 2017 | 639.38 Million EUR | -16.35% |
| 2016 | 764.36 Million EUR | 10.9% |
| 2015 | 689.22 Million EUR | -15.85% |
| 2014 | 819.04 Million EUR | 9.55% |
| 2013 | 747.62 Million EUR | 4.53% |
| 2012 | 715.23 Million EUR | -6.92% |
| 2011 | 768.41 Million EUR | -12.92% |
| 2010 | 882.4 Million EUR | -4.66% |
| 2009 | 925.5 Million EUR | 2.51% |
| 2008 | 902.8 Million EUR | 5.83% |
| 2007 | 853.08 Million EUR | 7.64% |
| 2006 | 792.54 Million EUR | 7.66% |
| 2005 | 736.13 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 497.21 Million EUR | -0.15% |
| 2024 Q1 | 248.8 Million EUR | -41.93% |
| 2023 Q1 | 232.5 Million EUR | -45.5% |
| 2023 Q3 | 209.26 Million EUR | -10.85% |
| 2023 FY | 898.8 Million EUR | 4.12% |
| 2023 Q4 | 428.45 Million EUR | 104.74% |
| 2023 Q2 | 234.73 Million EUR | 0.96% |
| 2022 Q2 | 218.38 Million EUR | -4.64% |
| 2022 Q1 | 229 Million EUR | 9.1% |
| 2022 FY | 863.24 Million EUR | 4.36% |
| 2022 Q4 | 426.61 Million EUR | 0.0% |
| 2021 Q1 | 220.6 Million EUR | -77.96% |
| 2021 Q3 | 191.4 Million EUR | -6.76% |
| 2021 Q2 | 205.29 Million EUR | -6.94% |
| 2021 FY | 827.19 Million EUR | -48.78% |
| 2021 Q4 | 209.89 Million EUR | 9.66% |
| 2020 Q2 | 184.7 Million EUR | -23.45% |
| 2020 Q3 | 187.79 Million EUR | 1.67% |
| 2020 FY | 1.61 Billion EUR | 88.8% |
| 2020 Q4 | 1 Billion EUR | 433.06% |
| 2020 Q1 | 241.3 Million EUR | 7.32% |
| 2019 FY | 855.33 Million EUR | 13.0% |
| 2019 Q4 | 224.83 Million EUR | 13.59% |
| 2019 Q2 | 208.15 Million EUR | -7.24% |
| 2019 Q3 | 197.94 Million EUR | -4.9% |
| 2019 Q1 | 224.4 Million EUR | 4.11% |
| 2018 Q1 | 189.3 Million EUR | 20.51% |
| 2018 FY | 756.93 Million EUR | 18.39% |
| 2018 Q2 | 178.13 Million EUR | -5.9% |
| 2018 Q4 | 215.53 Million EUR | 23.89% |
| 2018 Q3 | 173.97 Million EUR | -2.34% |
| 2017 Q4 | 157.08 Million EUR | 2.13% |
| 2017 FY | 639.38 Million EUR | -16.35% |
| 2017 Q2 | 152.37 Million EUR | -13.47% |
| 2017 Q3 | 153.8 Million EUR | 0.93% |
| 2017 Q1 | 176.1 Million EUR | -6.41% |
| 2016 Q4 | 188.16 Million EUR | 0.14% |
| 2016 FY | 764.36 Million EUR | 10.9% |
| 2016 Q1 | 184.9 Million EUR | 9.78% |
| 2016 Q3 | 187.9 Million EUR | -7.62% |
| 2016 Q2 | 203.39 Million EUR | 10.0% |
| 2015 Q4 | 168.42 Million EUR | 5.91% |
| 2015 Q3 | 159.03 Million EUR | -12.51% |
| 2015 Q2 | 181.76 Million EUR | 0.98% |
| 2015 FY | 689.22 Million EUR | -15.85% |
| 2015 Q1 | 180 Million EUR | -13.27% |
| 2014 Q1 | 201.6 Million EUR | -14.69% |
| 2014 FY | 819.04 Million EUR | 9.55% |
| 2014 Q4 | 207.54 Million EUR | -0.13% |
| 2014 Q3 | 207.8 Million EUR | 2.8% |
| 2014 Q2 | 202.14 Million EUR | 0.27% |
| 2013 Q3 | 167.5 Million EUR | -13.28% |
| 2013 FY | 747.62 Million EUR | 4.53% |
| 2013 Q1 | 170.3 Million EUR | 1896.02% |
| 2013 Q4 | 236.32 Million EUR | 41.09% |
| 2013 Q2 | 193.14 Million EUR | 13.41% |
| 2012 Q3 | 157.1 Million EUR | -9.62% |
| 2012 Q1 | 200.2 Million EUR | 13.42% |
| 2012 FY | 715.23 Million EUR | -6.92% |
| 2012 Q2 | 173.82 Million EUR | -13.18% |
| 2012 Q4 | 8.53 Million EUR | -94.57% |
| 2011 Q2 | 213.8 Million EUR | 0.52% |
| 2011 Q1 | 212.7 Million EUR | 3.3% |
| 2011 Q3 | 165.4 Million EUR | -22.64% |
| 2011 Q4 | 176.51 Million EUR | 6.72% |
| 2011 FY | 768.41 Million EUR | -12.92% |
| 2010 Q4 | 205.9 Million EUR | -0.77% |
| 2010 FY | 882.4 Million EUR | -4.66% |
| 2010 Q1 | 242.6 Million EUR | 8.21% |
| 2010 Q2 | 226.4 Million EUR | -6.68% |
| 2010 Q3 | 207.5 Million EUR | -8.35% |
| 2009 Q4 | 224.2 Million EUR | 5.51% |
| 2009 Q1 | 245 Million EUR | 0.0% |
| 2009 FY | 925.5 Million EUR | 2.51% |
| 2009 Q3 | 212.5 Million EUR | -12.84% |
| 2009 Q2 | 243.8 Million EUR | -0.49% |
| 2008 FY | 902.8 Million EUR | 5.83% |
| 2007 FY | 853.08 Million EUR | 7.64% |
| 2006 FY | 792.54 Million EUR | 7.66% |
| 2005 FY | 736.13 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Faes Farma, S.A. | 451.16 Million EUR | -98.267% |
| Laboratorio Reig Jofre, S.A. | 316.08 Million EUR | -182.996% |